Clinical Performance of BIS-GMA Free Dental Resin Composite

NCT ID: NCT05480852

Last Updated: 2022-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-20

Study Completion Date

2022-07-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Resin composites were introduced for restoring defective teeth commercially in the mid- 1960s as an alternative to acrylic resin and silicate cements. As one of the most significant contributions to dentistry, dental resin composites usually have three components as organic resin matrix, photo initiator system, and coupling agent treated inorganic fillers.

At present, the most commonly used organic resin matrix for dental resin composites are based on di-methacrrylates such as 2.2- bis \[p-(2- hydroxy-3- methacryloxypropoxy) penylene\] propane (Bis-GMA), ethoxylated bisGMA, 1,6-bis(2-methacryloyoxy-ethoxycarbonyl-amino)-2,4,4tri-methyl-hexane (UDMA) and triethyleneglycoldimethacrylate (TEGDMA).

The application of Bis-GMA has been doubted since it was reported to have estrogenic activity in a cell culture assay.Though later studies have showed that Bis-GMA does not hydrolyse into the estrogenic substance BPA, BPA has still been detected to be release out of several commercial Bis-GMA-based dental restorative materials. Although there is a lack of studies analysing the association between BPA exposure from dental materials and its adverse effects on human health, there is a need to develop newer BPA-free resin composites to minimize human exposure to this compound. Accordingly, the objective of this study was to evaluate the performance of BIS- GMA- free composite as a photopolymerizable posterior dental composite restoration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypothesis: The null hypothesis is that there is no difference in using the new BIS- GMA- free composite.

Aim of the study: This clinical trial was conducted to compare the clinical performance of the new BIS- GMA- free composite versus BIS-GMA- containing composite in the management of carious lesion in adult patients over 9 months. The two types of composites will be evaluated using USPHS criteria for:

* Retention (R).
* Contact (C).
* Color match (CM).
* Marginal adaptation (MA).
* Marginal discoloration (MD).
* Anatomic form (AF).
* Secondary caries (SC).
* Surface texture (ST).
* Gingival inflammation (GI).
* Post-operative sensitivity (POS).
* Patient complaints (PC).
* Patient satisfaction (PS).
* The evaluation done by three calibrated operators.

The study was conducted in Operative Dentistry Department, Faculty of Dentistry, Menia University.

The researcher was bear ultimate responsibility for all activities associated with the conduct of a research project including recruitment of patients, explaining, and performing the procedures to them.

\- Intervention:

BIS- GMA- free composite material:

Tooth preparation and restoration was carried out using magnifying loops. All cavities were restored using composite resin. cavities, including the dentin, were acid etched for 30 s, rinsed thoroughly for 15 s, bonded with universal adhesive and light cured for 10 s prior to placing the filling material.

Restorations were light cured for 20 s, check the occlusion, finished with diamond burs and polished with Kenda hybrid composite pre- and super-polishers (Kenda, Vaduz, Liechtenstein).

\- Comparator:

BIS- GMA- containing composite material:

The same methodology of the intervention BIS-GMA- free composite material If the patient showed any complications during our clinical trial toward either the intervention (BIS- GMA- free composite) or the comparator (BIS-GMA containing composite material), the trial will be stopped at once and all the needed management against any complications will be done.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Therapeutics

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Bis-GMA free dental resin composite Bis-GMA containing dental resin composite Clinical performance Modified US Public Health Service Clinical Criteria (USPHS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bis-GMA Free dental resin composite

Restorative Materials

Group Type EXPERIMENTAL

Bis-GMA Free dental resin composite

Intervention Type OTHER

Restorative Material

Bis-GMA containing dental resin composite

Restorative Materials

Group Type ACTIVE_COMPARATOR

Bis-GMA Free dental resin composite

Intervention Type OTHER

Restorative Material

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bis-GMA Free dental resin composite

Restorative Material

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have been from 20 to 45 years of age.
* The two studied materials restorations should be used in approximately the same sized lesions or within the same extension.
* The patient will be reimbursed for attending for the clinical evaluation(s) of their restorations.
* Be a regular dental attender who agree to return for assessments.

Exclusion Criteria

* There was a history of any adverse reaction to clinical materials of the type to be used in the study.
* There was evidence of occlusal parafunction and/or pathological tooth wear.
* patients whose history revealed parafunctional habits or use of medications that potentially could cause hyposalivation.
* They are pregnant or have medical and/or dental histories which could possibly complicate their attendance for the assessment of the restorations and/ or influence the behavior and performance of the restorations in the clinical service.
* They were irregular dental attenders.
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sara Ahmed Reda Mohamed

Assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sara A Reda, Phd

Role: PRINCIPAL_INVESTIGATOR

Faculty of Dentistry, Minia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sara Ahmed Reda Mohamed

Minya, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Reda SA, Hussein YF, Riad M. The impact of Bis-GMA free and Bis-GMA containing resin composite as posterior restoration on marginal integrity: a randomized controlled clinical trial. BMC Oral Health. 2023 Dec 19;23(1):1022. doi: 10.1186/s12903-023-03759-5.

Reference Type DERIVED
PMID: 38114979 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Faculty of Dentistry

Identifier Type: -

Identifier Source: org_study_id